1. Ang AJ, Sharma AA, Sharma A. Nephrolithiasis: approach to diagnosis and management. The Indian Journal Of Pediatrics. 2020;87:716-25. [
DOI:10.1007/s12098-020-03424-7] [
PMID]
2. Arafa MA, Rabah DM. Study of quality of life and its determinants in patients after urinary stone fragmentation. Health and quality of life outcomes. 2010;8:1-6. [
DOI:10.1186/1477-7525-8-119] [
PMID] [
]
3. Shahsavari S. An overview of the most important medicinal plants used in iranian traditional medicine for the treatment of kidney stones: A mini-review article. Plant Biotechnology Persa. 2021;3(1):37-8. [
DOI:10.52547/pbp.3.1.4]
4. Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clinical journal of the American Society of Nephrology. 2016;11(3):488-96. [
DOI:10.2215/CJN.07610715] [
PMID] [
]
5. Fadl AA, Pasha ZE, Abanumay AA, Baz AM, Hariri LMN, Alghamdi A, et al. Prevalence and Pathophysiology of Pediatric Urolithiasis-A Review. EPIDEMIOLOGY.7(16):17.
6. Lamprecht KJ. Nephrolithiasis Nutrition Therapy in the Pediatric Population. Nutritional and Medical Management of Kidney Stones. 2019:273-80. [
DOI:10.1007/978-3-030-15534-6_24]
7. Panzarino V. Urolithiasis in children. Advances in Pediatrics. 2020;67:105-12. [
DOI:10.1016/j.yapd.2020.03.004] [
PMID]
8. Tohidi MR, Seyedzadeh A, Seyedzadeh MS, Ahmadian R, Hookari S. Prevalence of metabolic risk factors affecting childhood nephrolithiasis: A report from a university hospital in west of Iran. International Journal of Pediatrics. 2020;8(8):11691-9.
9. Raizenne BL, Deyirmendjian C, Lafontaine M-L, Balde M, Bechis SK, Sur RL, et al. The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life. Journal of Endourology. 2023;37(12):1289-94. [
DOI:10.1089/end.2023.0132] [
PMID]
10. Raja A, Wood F, Joshi HB. The impact of urinary stone disease and their treatment on patients' quality of life: a qualitative study. Urolithiasis. 2020;48(3):227-34. [
DOI:10.1007/s00240-019-01142-0] [
PMID] [
]
11. Omar AM, Kamal NN, Abdelmgeed AS, Abdelrehim MG. Epidemiology of urinary stones in children Attending Minia University Hospital for Urology. Minia Journal of Medical Research. 2024;35(1):16-23. [
DOI:10.21608/mjmr.2024.257978.1577]
12. Spivacow FR, Del Valle EE, Boailchuk JA, Sandoval Díaz G, Rodríguez Ugarte V, Arreaga Álvarez Z. Metabolic risk factors in children with kidney stone disease: an update. Pediatric Nephrology. 2020;35:2107-12. [
DOI:10.1007/s00467-020-04660-x] [
PMID]
13. Skolarikos A, Neisius A, Petřík A, Somani B, Thomas K, Gambaro G, et al., editors. Urolithiasis. EAU Guidelines Edn presented at the EAU Annual Congress Amsterdam; 2022.
14. Emokpae M, Gadzama A. Anatomical distribution and biochemical composition of urolithiasis in Kano, northern Nigeria. International Journal of Biological and Chemical Sciences. 2012;6(3):1158-66. [
DOI:10.4314/ijbcs.v6i3.21]
15. Momtaz HE, Esna Ashari F. Frequency of Metabolic Risk Factors in Children with Urinary Tract Stones Referred to Hamadan Pediatric Nephrology Clinic. Avicenna Journal of Clinical Medicine. 2012;19(2):11-5.
16. Del Valle E, Spivacow F, Zanchetta J. Metabolic evaluation at the time of the first renal lithiasis episode. Medicina. 1995;55(1):69-74.
17. Aladaileh SH, Abukhalil MH, Saghir SA, Hanieh H, Alfwuaires MA, Almaiman AA, et al. Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. 2019;9(8):346. [
DOI:10.3390/biom9080346] [
PMID] [
]
18. Mohkam M, Otoukesh B, Sharifian M, Dalirani R, Hatamian B. Epidemiology of urolithiasis among children hospitalized in Mofid hospital during 5 years. Pajoohandeh Journal. 2010;15(3):133-6.
19. Amancio L, Fedrizzi M, Bresolin NL, Penido MGMG. Pediatric urolithiasis: experience at a tertiary care pediatric hospital. Brazilian Journal of Nephrology. 2016;38:90-8. [
DOI:10.5935/0101-2800.20160014] [
PMID]